Extended 10-Panel
Broad 10-substance screening covering CDT, cocaine, ketamine, amphetamines, 3-MMC, LSD, GHB, phenibut, heroin marker, and opiates.
The Zuiver PCP urine screening provides reliable, qualitative detection of phencyclidine and its metabolites. This test is suitable for workplace compliance programmes, offering clear results within established cut-off thresholds.
Doctor's Assessment Included
This test detects the presence of phencyclidine (PCP) and its metabolites in urine. PCP is a synthetic dissociative substance originally developed as an anaesthetic agent. The test provides a qualitative result indicating whether PCP metabolites are present above the assay cut-off level.
PCP use may be associated with serious health effects including agitation, psychosis, and cardiovascular complications. Detection is relevant for workplace safety programmes, clinical treatment monitoring, and forensic investigations. Consult a healthcare professional for interpretation of results.
Testing may be relevant in the context of workplace drug screening programmes, substance abuse treatment monitoring, emergency department evaluations, or when PCP use is suspected. Consult a healthcare professional for guidance on when testing is appropriate.
Maintain a healthy lifestyle with regular physical activity and a balanced diet. If you have concerns about substance use, seek support from a qualified healthcare professional or counselling service. Stay well-hydrated and prioritise mental well-being.
These panels measure values from the same category as this marker.
Broad 10-substance screening covering CDT, cocaine, ketamine, amphetamines, 3-MMC, LSD, GHB, phenibut, heroin marker, and opiates.
Screen for 5 commonly requested substances including CDT, cocaine, ketamine, amphetamines, and 3-MMC.
CDT biomarker test designed to indicate chronic alcohol consumption patterns.
Individual cocaine metabolite screening with laboratory confirmation.
Phencyclidine (PCP)
€179,-